PASADENA, Calif., Jan. 28, 2021 /PRNewswire/ -- SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.
Search
Recent Posts
See AllBy: Rebecca Torrence The Centers for Medicare & Medicaid Services (CMS) will fund four states to expand telehealth and other healthcare services in their rural communities. Four organizations are set
CarDon & Associates turned to Third Eye Health for a telehealth solution. The telehealth technology offered fast connectivity with access to board-certified, state-licensed physicians who are trained
By: Kayla Blanton Since the onset of the pandemic, demand for therapy and mental health services has skyrocketed. According to a November 2020 poll from the American Psychological Association (APA), 7